MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific DPO 2011-2026 | TMO
DPO Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 49.3 | 43.7 | 45.4 | 34.1 | 32.6 | 31.9 | 33.4 | 32.5 | 33.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 49.3 | 31.9 | 37.3 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 203.78 | -0.37 % | $ 22.6 B | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
4.24 K | $ 4.88 | 8.44 % | $ 6.49 M | USA |
 |
Fulgent Genetics
FLGT
|
35.2 | $ 18.93 | 2.32 % | $ 583 M | USA |
 |
Castle Biosciences
CSTL
|
65.8 | $ 21.08 | - | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
196 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
11 | $ 144.59 | -4.76 % | $ 11.3 B |  Irlanda |
 |
Illumina
ILMN
|
57.1 | $ 162.47 | 1.52 % | $ 25.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
48.6 | $ 130.7 | 0.45 % | $ 16.4 B | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 23.46 | 3.12 % | $ 1.25 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
33 | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 100.24 | 0.26 % | $ 6.77 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 186.29 | -1.88 % | $ 9.23 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
59.7 | $ 1.37 | - | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 465.73 | -0.23 % | $ 13.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 133.03 | -2.58 % | $ 23.4 B |  Schweiz |
 |
NeoGenomics
NEO
|
19.7 | $ 11.28 | -1.4 % | $ 1.44 B | USA |
 |
Myriad Genetics
MYGN
|
45.9 | $ 4.43 | -2.42 % | $ 410 M | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 21.28 | 7.75 % | $ 476 M | USA |
 |
Natera
NTRA
|
17.9 | $ 216.5 | -2.84 % | $ 29.6 B | USA |
 |
Personalis
PSNL
|
65.7 | $ 9.61 | -1.44 % | $ 858 M | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 7.3 | -1.75 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
1.44 K | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.02 | -1.51 % | $ 4.64 M | USA |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 67.77 | -3.27 % | $ 4.05 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 268.63 | -0.96 % | $ 22.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
163 | $ 0.69 | 3.51 % | $ 248 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
62.7 | $ 9.17 | -1.29 % | $ 1.99 B | USA |
 |
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | USA |